Numerate receives NIH funding to discover new anti-arrhythmic treatments
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has awarded a small business innovation research (SBIR) Phase I grant to Numerate to boost a new drug programme for cardiac arrhythmias.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Arrhythmia | Cardiac Arrhythmia | Cardiology | Funding | Grants | Heart | National Institutes of Health (NIH) | Pharmaceuticals | Small Businesses